Medicines and Healthcare products Regulatory Agency

MANUFACTURER'S AUTHORISATION
1: Authorisation Number UK MIA(IMP) 29595
2: Name of authorisation holder PIRAMAL HEALTHCARE UK LIMITED
3: Address(es) of manufacturing site(s)

PIRAMAL HEALTHCARE UK LIMITED, EARLS ROAD, GRANGEMOUTH, FK3 8XG, UNITED KINGDOM

PIRAMAL HEALTHCARE UK LIMITED , WHALTON ROAD, MORPETH, NORTHUMBERLAND, NE61 3YA, UNITED KINGDOM

PIRAMAL HEALTHCARE UK LIMITED, 2 ROSELAND HALL, EARLS GATE PARK, GRANGEMOUTH, FK3 8ZF, UNITED KINGDOM

4: Legally registered address of authorisation holder PIRAMAL HEALTHCARE UK LIMITED, WHALTON ROAD, MORPETH, NORTHUMBERLAND, NE61 3YA, UNITED KINGDOM
5: Scope of authorisation and dosage forms ANNEX 1 and/ or ANNEX 2
6: Legal Basis of authorisation
7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation Confidential
8: Authorisation Date 15/03/2024
9: Annexes attached Annex 1 and/or Annex 2
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:

PIRAMAL HEALTHCARE UK LIMITED, EARLS ROAD, GRANGEMOUTH, FK3 8XG, UNITED KINGDOM

Human Investigational Medicinal Products
Authorised Operations
Authorised Operations
MANUFACTURING OPERATIONS (according to part 1)
Operations
Part 1 - MANUFACTURING OPERATIONS
[ 1.2 ] Non-sterile investigational medicinal products
    [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms)
        [ 1.2.1.15 ] Other non-sterile medicinal products
            Liquid conjugate bulk drug substances in solution
            Special Requirements
            Including cytotoxic and potent bulk drug substances
    [ 1.2.2 ] Batch certification
[ 1.3 ] Biological investigational medicinal products
    [ 1.3.1 ] Biological medicinal products
        [ 1.3.1.8 ] Other biological medicinal products
            QP certification of the manufacturing and testing conducted on Liquid conjugate bulk drug substances in solution
            Special Requirements
            Including cytotoxic and potent bulk drug substances
    [ 1.3.2 ] Batch certification
        [ 1.3.2.8 ] Other biological medicinal products
            QP certification of the manufacturing and testing conducted on Liquid conjugate bulk drug substances in solution
            Special Requirements
            Including cytotoxic and potent bulk drug substances
[ 1.6 ] Quality control testing
    [ 1.6.2 ] Microbiological: non-sterility
    [ 1.6.3 ] Chemical/Physical
    [ 1.6.4 ] Biological
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:

PIRAMAL HEALTHCARE UK LIMITED , WHALTON ROAD, MORPETH, NORTHUMBERLAND, NE61 3YA, UNITED KINGDOM

Human Investigational Medicinal Products
Authorised Operations
Authorised Operations
MANUFACTURING OPERATIONS (according to part 1)
IMPORTATION OF MEDICINAL PRODUCTS (according to part 2)
Operations
Part 1 - MANUFACTURING OPERATIONS
[ 1.2 ] Non-sterile investigational medicinal products
    [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms)
        [ 1.2.1.1 ] Capsules, hard shell
        [ 1.2.1.13 ] Tablets
            Special Requirements
            Range of hormonal property tablets
        [ 1.2.1.15 ] Other non-sterile medicinal products
            Tablet/ medical device combination. Over encapsulation of a rangedosage forms
    [ 1.2.2 ] Batch certification
[ 1.3 ] Biological investigational medicinal products
    [ 1.3.2 ] Batch certification
        [ 1.3.2.5 ] Biotechnology products
[ 1.5 ] Packaging
    [ 1.5.1 ] Primary packaging
        [ 1.5.1.1 ] Capsules, hard shell
        [ 1.5.1.13 ] Tablets
        [ 1.5.1.15 ] Other non-sterile medicinal products
            Packaging of a range of over encapsulated range of products. Packaging of tablet/ medical device combination
    [ 1.5.2 ] Secondary packaging
[ 1.6 ] Quality control testing
    [ 1.6.2 ] Microbiological: non-sterility
    [ 1.6.3 ] Chemical/Physical
Part 2 - IMPORTATION OF MEDICINAL PRODUCTS
[ 2.1 ] Quality control testing of imported medicinal products
    [ 2.1.2 ] Microbiological: non-sterility
    [ 2.1.3 ] Chemical/Physical
[ 2.2 ] Batch certification of imported medicinal products
    [ 2.2.1 ] Sterile Products
        [ 2.2.1.1 ] Aseptically prepared
        [ 2.2.1.2 ] Terminally sterilised
    [ 2.2.2 ] Non-sterile products
    [ 2.2.3 ] Biological medicinal products
        [ 2.2.3.5 ] Biotechnology products
[ 2.3 ] Other Importation Activities
    [ 2.3.1 ] Site of Physical Importation
    [ 2.3.2 ] Importation of Intermediate which undergoes further processing
    [ 2.3.4 ] Other
        Batch Certification of products imported into EU but not to the Piramal Morpeth site
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:

PIRAMAL HEALTHCARE UK LIMITED, 2 ROSELAND HALL, EARLS GATE PARK, GRANGEMOUTH, FK3 8ZF, UNITED KINGDOM

Human Investigational Medicinal Products
Authorised Operations
Authorised Operations
MANUFACTURING OPERATIONS (according to part 1)
Operations
Part 1 - MANUFACTURING OPERATIONS
[ 1.2 ] Non-sterile investigational medicinal products
    [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms)
        [ 1.2.1.15 ] Other non-sterile medicinal products
            Liquid conjugate bulk drug substances in solution
            Special Requirements
            Including cytotoxic and potent bulk drug substances
[ 1.3 ] Biological investigational medicinal products
    [ 1.3.1 ] Biological medicinal products
        [ 1.3.1.8 ] Other biological medicinal products
            QP batch certification of the manufacturing and testing conducted on liquid conjugate bulk drug substances in solution
            Special Requirements
            Including cytotoxic and potent bulk drug substances
[ 1.6 ] Quality control testing
    [ 1.6.2 ] Microbiological: non-sterility
    [ 1.6.3 ] Chemical/Physical
    [ 1.6.4 ] Biological